The RxWiki Digital Pharmacist stamp of approval lets you know that this content has been created and reviewed by a licensed pharmacist.
Metoprolol should be taken with or immediately after a meal.
Avoid drinking alcohol while taking metoprolol.
The extended-release tablets (metoprolol succinate) should not be crushed or chewed. However, they may be split along the score line if necessary.
If you have diabetes metoprolol and other beta blockers may mask the warning signs of low blood sugar levels. For example, you may not develop palpitations (rapid, or irregular heartbeats) or tremor, which tend to occur if blood sugar levels are too low.
WarningsView FDA Warning
Metoprolol is a prescription medication used to treat high blood pressure, angina (chest pain), congestive heart failure, and to improve survival after a heart attack. Metoprolol belongs to a group of drugs called beta blockers, which work by relaxing blood vessels and slowing heart rate. This improves blood flow and decreases overall blood pressure.
This medication comes in an immediate-release tablet (metoprolol tartrate), an extended-release tablet (metoprolol succinate) and in an injectable form (metoprolol tartrate).
Common side effects include fatigue, tiredness, and shortness of breath. Metoprolol can cause drowsiness. Do not drive or operate heavy machinery until you know how metoprolol affects you.
Uses of Metoprolol
Metoprolol is a prescription medication used alone or in combination with other medications for the following conditions:
- to control high blood pressure
- angina (chest pain)
- in the treatment of congestive heart failure
- to improve survival after a heart attack
This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.
Metoprolol Brand Names
Metoprolol may be found in some form under the following brand names:
Metoprolol Drug Class
Metoprolol is part of the drug class:
Side Effects of Metoprolol
Serious side effects have been reported with metoprolol. See the “Drug Precautions” section.
Common side effects include:
- shortness of breath
- a slow heart beat
- low blood pressure
This is not a complete list of metoprolol side effects. Ask your doctor or pharmacist for more information.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Tell your doctor about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements. Especially tell your doctor if you take:
- reserpine (Serpalan, Serpasil)
- monoamine oxidase inhibitors such as tranylcypromine (Parnate), phenelzine (Nardil), selegiline (Eldepryl, Zelapar), isocarboxazid (Marplan), and rasagiline (Azilect)
- medications that block the enzyme CYP2D6 such as paroxetine (Paxil), quinidine (Cardioquin, Duraquin, Quinora), and fluoxetine (Sarafem, Prozac)
- digoxin (Lanoxin)
- clonidine (Catapres)
- calcium channel blockers such as nifedipine (Adalat, Nifedical, Procardia), amlodipine (Novasc), verapamil (Calan, Isoptin, Covera, Verelan), and diltiazem (Cardizem)
This is not a complete list of metoprolol drug interactions. Ask your doctor or pharmacist for more information.
Serious side effects have been reported with metoprolol including the following:
- heart failure. Tell your healthcare provider right away if you experience any of the following symptoms of heart failure:
- sudden weight gain
- worsening shortness of breath
- increased swelling of your feet, legs, or abdomen
- needing to use more pillows to go to sleep or sleeping in a recliner
- waking from sleep to catch your breath
- a cough that does not go away
- new or increasing irregularities in your heart rate
- diabetes and low blood sugar. Metoprolol may mask symptoms of low blood sugar in those with diabetes. Tell your health care provider right away if you have the following symptoms of hypoglycemia:
- thyrotoxicosis. Metoprolol may mask symptoms of thyrotoxicosis in those with hyperthyroidism. Avoid abrupt withdrawal of taking metoprolol, which might result in a thyroid storm, a life-threatening situation if left untreated.
- asthma or other bronchospastic conditions. Metoprolol may be used with caution in patients with bronchospastic disease who do not respond to, or cannot tolerate, other similar types of treatment. Tell your health care provider right away if you have the following symptoms of a bronchospasm or asthma attack:
- difficulty breathing
- chest pain
- chest tightness
- slow heart beat (bradycardia) and/or low blood pressure. Tell your health care provider right away if you have the following symptoms of bradycardia and/or low blood pressure:
- feeling as if you are going to faint
- chest pain
- shortness of breath
- blurry vision
Metoprolol can cause drowsiness. Do not drive or operate heavy machinery until you know how metoprolol affects you.
Metoprolol can cause serious withdrawal side effects. To avoid these side effects, do not suddenly stop taking this medication. Discuss with your doctor about slowly decreasing the dose before stopping use of this medication altogether.
Do not take metoprolol if you:
- are allergic to metoprolol or to any of its ingredients
- have severe bradycardia
- have heart block greater than first degree
- are experiencing angiogenic shock
- have decompensated cardiac failure
- have sick sinus syndrome without a pacemaker
- have peripheral arterial circulatory disorders
Metoprolol Food Interactions
Medications can interact with certain foods. In some cases, this may be harmful and your doctor may advise you to avoid certain foods. In the case of metoprolol, there are no specific foods that you must exclude from your diet when receiving this medication.
Before taking metoprolol, tell your doctor about all of your medical conditions. Especially tell your doctor if you:
- have thyrotoxicosis
- have asthma or other bronchospastic disease
- have about to undergo any type of surgery, including dental surgery
- have liver problems
- have thyroid problems
- have heart problems
- have severe bradycardia
- are experiencing angiogenic shock
- have peripheral arterial circulatory disorders
- are pregnant or breastfeeding
Tell your doctor about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements.
Metoprolol and Pregnancy
Tell your doctor if you are pregnant or plan to become pregnant.
The FDA categorizes medications based on safety for use during pregnancy. Five categories - A, B, C, D, and X, are used to classify the possible risks to an unborn baby when a medication is taken during pregnancy.
Metoprolol falls into category C. In animal studies, pregnant animals were given this medication and had some babies born with problems. No well-controlled studies have been done in humans, though. Therefore, this medication may be used if the potential benefits to the mother outweigh the potential risks to the unborn child.
Metoprolol and Lactation
Tell your doctor if you are breastfeeding or plan to breastfeed.
Metoprolol has been detected in human breast milk. Because of the possibility for adverse reactions in nursing infants from metoprolol, a choice should be made whether to stop nursing or to stop use of this medication. The importance of the drug to the mother should be considered.
Take metoprolol exactly as prescribed.
This medication comes in tablet and in an injectable form (metoprolol tartrate). The tablet is taken once or twice daily. The injectable form is given directly into a vein (IV) by a healthcare professional.
Metoprolol also comes in an extended-release tablet (metoprolol succinate). The extended-release tablet is taken once a day.
Take metoprolol at the same time each day.
Do not chew, divide, or break metoprolol tablets. Swallow tablets whole.
If you miss a dose, take the missed dose as soon as you remember. If it is almost time for the next dose, skip the missed dose and take your next dose at the regular time. Do not take two doses of metoprolol at the same time.
Take metoprolol exactly as prescribed by your doctor. Follow the directions on your prescription label carefully.
The metoprolol dose your doctor recommends will be based on the following:
- the condition being treated
- other medical conditions you have
- other medications you are taking
- how you respond to this medication
- your age
The recommended dose range for metoprolol [tartrate] for treating hypertension is 100 to 450 mg, either taken once a day or twice a day in equally divided doses.
The recommended dose range for metoprolol [tartrate] for treating chest pain is 100 to 400 mg, either taken once a day or twice a day in equally divided doses.
The recommended dose for metoprolol [tartrate] for treating a heart attack is 15 mg at first (by injection), then 25 to 50 mg every 6 hours for the first 48 hours, then 100 mg twice a day in equally divided doses.
The recommended dose range for metoprolol [succinate] for treating hypertension in adults is 25 to 100 mg once a day.
The recommended dose range for metoprolol [succinate] for treating hypertension in children (6 years of age or older) is 0.1 mg/kg to 50 mg once a day.
The recommended dose range for metoprolol [succinate] for treating chest pain is 100 to 400 mg once a day.
The recommended dose range for metoprolol [succinate] for treating heart failure is 12.5 to 200 mg once a day.
If you take too much metoprolol, call your healthcare provider or local Poison Control Center, or seek emergency medical attention right away.
- Store metoprolol at room temperature between 15 and 30°C (59- 86°F).
- Protect from moisture and heat.
- Keep it in the original container.
- Keep this and all medications out of the reach of children.
Metoprolol FDA Warning
Following abrupt cessation of therapy with certain beta-blocking agents, exacerbations of angina pectoris and, in some cases, myocardial infarction have occurred. When discontinuing chronically administered metoprolol, particularly in patients with ischemic heart disease, the dosage should be gradually reduced over a period of 1 - 2 weeks and the patient should be carefully monitored. If angina markedly worsens or acute coronary insufficiency develops, metoprolol administration should be reinstated promptly, at least temporarily, and other measures appropriate for the management of unstable angina should be taken. Warn patients against interruption or discontinuation of therapy without the physician’s advice. Because coronary artery disease is common and may be unrecognized, it may be prudent not to discontinue metoprolol therapy abruptly even in patients treated only for hypertension
Related Clinical Trials
- Nebivolol and Endothelial Regulation of Fibrinolysis (NERF)
- Sarpogrelate Drug Interaction
- Co-Administration of MK-4618 With Antihypertensive Agents (MK-4618-010 AM1)
- Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome
- Risk Factor Control Before Orthopedic Surgery
- Comparison of Efficacy of Ivabradine Versus Metoprolol
- Treatment of Ventricular Tachyarrhythmias Refractory To Shock With Beta Blockers: The SHOCK and BLOCK Trial
- Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension
- Glycemic Control Of Carvedilol Versus Metoprolol In Patients With Type II Diabetes Mellitus And Hypertension
- Pharmacokinetic Study to Investigate Low-dose Combinations of a Cocktail of Seven Drugs for Simultaneous Phenotyping of Cytochromes
- Carvedilol for Prevention of Paroxysmal Atrial Fibrillation
- Intravenous Metoprolol Versus Intravenous Amiodarone in the Prevention of Atrial Fibrillation After Cardiac Surgery
- Study to Evaluate the Effect of Eliglustat on the Pharmacokinetics, Safety and Tolerability of Metoprolol in Healthy Adults
- Comparing the Effects of Two Beta Blockers,Metoprolol and Nebivolol,on Ambulatory Blood Pressure and Basal Metabolic Rate
- A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for Hypertension
- A Study of the Effect of LY2189265 on Two Blood Pressure Drugs
- Tight Hemodynamic Control in Patients Who Are Chronically on Metoprolol
- Comparison of Diltiazem and Metoprolol in the Management of Acute Atrial Fibrillation or Atrial Flutter
- Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects
- Drug Interaction Study of Pyronaridine-artesunate and Metoprolol and Pyronaridine-artesunate Re-dosing Study in Healthy Volunteers
- Evaluation of the Long-Term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension
- The Influence of Heart Rate Reduction Upon Central Arterial Pressure in Younger and Older Healthy Individuals
- PREvention of Atrial Fibrillation in patientS Undergoing thorAcic surGEry for Lung Cancer
- Sympathetic Nervous System Modulation in Hypertension
- The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial
- Effect of BMS-914392 on Pharmacokinetics of Metoprolol
- Rate Control in Atrial Fibrillation
- Nebivolol Versus Metoprolol: Comparative Effects on Fatigue and Quality of Life
- Renal Denervation in Patients After Acute Coronary Syndrome
- Use of Beta Blockers in Elderly Trauma Patients
- Combined Renin Inhibition/Beta-blockade
- Coreg CR, Blood Vessel Stiffness and Blood Vessel Function
- Clonidine to Prevent Implantable Cardiovertor Defibrillator Firing
- A Comparison of the Effect of Carvedilol and Metoprolol on Airways Tone in Patients With Heart Failure
- Effects of Heart Rate Reduction on Central Arterial Pressure in Healthy Individuals
- Vascular Effects of Carvedilol Versus Metoprolol in Hypertensive Patients With Type 2 Diabetes
- Effect of Metoprolol on Thalassemia Cardiomyopathy
- Beta-Blocker Before Extubation
- Drug Interaction Study of SAR302503 in Patients With Solid Tumor
- Nebivolol and the Endothelin (ET)-1 System
- The Effectiveness of Metoprolol in the Prevention of Syncope Recurrence in Children and Adolescents
- Nebivolol Effect on Nitric Oxide Levels, Blood Pressure, and Renal Function in Kidney Transplant Patients
- Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy
- Efficacy and Safety of Adding Clopidogrel to Aspirin or Use of Metoprolol in Myocardial Infarction
- Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives
- Prevention of Anthracycline or Trastuzumab Induced Cardiomyopathy by Metoprolol
- Systolic Hypertension in the Elderly Program (SHEP) (Pilot Study)
- Effect of Beta Blockade on Left Ventricular Remodeling and Function in Moderate to Severe Asymptomatic Aortic Regurgitation
- Metoprolol and Formoterol in Chronic Obstructive Pulmonary Disease (COPD)
- A Weight Loss Study in Overweight Men and Women
- Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)
- Heart Rate Variability (HRV) to Evaluate Surgical Risk on Patients on Beta Blockers
- Pain Relief of Metoprolol Versus Metoprolol Plus Morphine in Acute Chest Pain
- To Compare Blood and Urine Concentrations of Mirabegron (YM178) in Healthy Poor or Extensive Metabolizers for CYP2D6 and to Assess the Effect of Mirabegron on the Metabolism of Metoprolol
- Beta-2 Polymorphisms and Beta Receptor Selectivity
- Randomized Trial Comparing Diltiazem and Metoprolol For Atrial Fibrillation Rate Control
- Comparison of Bisoprolol With Metoprolol Succinate Sustained-release on Heart Rate and Blood Pressure in Hypertensive Patients
- Effect of Losartan on Retinal Endothelial Function in Patients With Essential Hypertension
- Economic Impact of Switching From Metoprolol to Nebivolol for Hypertension Treatment
- Repeated Dose Study for the Investigation of Heritability of and Genetic Influences on Drug Pharmacokinetics
- RATAF -RATe Control in Atrial Fibrillation
- Impact of Nebivolol on Central Aortic Pressure
- Comparison of Blood Pressure Medications on Metabolism
- A Comparison of the Effects of Intraoperative Administration of Metoprolol or Esmolol on General Anesthetic Requirement
- Pharmacogenomic Evaluation of Antihypertensive Responses 2